Edgestream Partners L.P. Increases Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Edgestream Partners L.P. boosted its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 119.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 10,472 shares of the company’s stock after purchasing an additional 5,702 shares during the quarter. Edgestream Partners L.P.’s holdings in Henry Schein were worth $725,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the company. Versant Capital Management Inc boosted its holdings in shares of Henry Schein by 274.6% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after buying an additional 335 shares during the last quarter. Venturi Wealth Management LLC raised its stake in Henry Schein by 3,347.1% during the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock worth $41,000 after acquiring an additional 569 shares during the period. Quent Capital LLC raised its stake in Henry Schein by 91.2% during the 4th quarter. Quent Capital LLC now owns 677 shares of the company’s stock worth $47,000 after acquiring an additional 323 shares during the period. Smartleaf Asset Management LLC raised its stake in Henry Schein by 23.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock worth $52,000 after acquiring an additional 143 shares during the period. Finally, City State Bank bought a new stake in Henry Schein during the 4th quarter worth approximately $55,000. 96.62% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Stock Performance

NASDAQ HSIC opened at $69.94 on Thursday. The stock has a market cap of $8.68 billion, a PE ratio of 28.78, a P/E/G ratio of 2.13 and a beta of 0.90. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.49. The stock has a fifty day simple moving average of $74.77 and a 200-day simple moving average of $72.64.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. During the same quarter last year, the firm posted $0.66 EPS. The company’s revenue for the quarter was up 5.8% on a year-over-year basis. Equities analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on HSIC shares. Barrington Research reissued an “outperform” rating and issued a $90.00 target price on shares of Henry Schein in a report on Wednesday, February 26th. UBS Group cut their target price on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a report on Wednesday, February 26th. Wells Fargo & Company began coverage on shares of Henry Schein in a research note on Friday, February 14th. They set an “equal weight” rating and a $80.00 price objective for the company. Mizuho began coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price objective for the company. Finally, Jefferies Financial Group lifted their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Six equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $81.10.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.